Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVP-2203 for Primary Hypercholesterolemia
NCT05856487Phase 3Unknown
- Sponsor
- NVP Healthcare Co., Ltd.
- Start
- Jun 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of NVP-2203-R2 in hypercholesterolemia, sponsored by NVP Healthcare Co., Ltd.. Status: unknown.
02
Drugs
NVP-2203-R2
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT05856487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05856487.